When did figs IPO 2021?
When did FIGS IPO? (FIGS) raised $394 million in an IPO on Thursday, May 27th 2021. The company issued 22,500,000 shares at $16.00-$19.00 per share. Goldman Sachs, Morgan Stanley, Barclays, Credit Suisse and BofA Securities acted as the underwriters for the IPO.
What are analysts’1 year price targets for figs stock?
11 brokerages have issued 1 year price targets for FIGS’s stock. Their forecasts range from $28.00 to $50.00. On average, they anticipate FIGS’s share price to reach $41.91 in the next twelve months.
Who bought figs stock?
FIGS stock was purchased by a variety of institutional investors in the last quarter, including Sib LLC, Bedel Financial Consulting Inc., and National Bank of Canada FI. View insider buying and selling activity for FIGS or or view top insider-buying stocks. How do I buy shares of FIGS?
When is figs’s next quarterly earnings announcement?
FIGS is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022. View our earnings forecast for FIGS. How were FIGS’s earnings last quarter?
Is FIGS a good stock buy?
Figs shows many of the signs of a good, long-term investment. It is a growing brand with a passionate following. Its differentiated product, high net promoter score, and DTC model enable it to generate solid gross margins and revenue growth.
What is the DARE stock forecast for 2021?
Dare Bioscience Inc (NASDAQ:DARE) The 5 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 6.00, with a high estimate of 17.00 and a low estimate of 3.00. The median estimate represents a +347.76% increase from the last price of 1.34.
What Will MSFT stock be in 5 years?
Based on our forecasts, a long-term increase is expected, the “MSFT” stock price prognosis for 2027-06-25 is 592.308 USD. With a 5-year investment, the revenue is expected to be around +123.66%. Your current $100 investment may be up to $223.66 in 2027. Get It Now!
Why is FIGS stock going down?
Figs stock down as the medical scrubs maker runs into supply chain snags.
Is DARE still a thing?
The DARE program lost funding in 1998 and has since been replaced by the keepin’ it REAL program (kiR). This program is more interactive based on the criticism that DARE workshops just consisted of police officers standing up and talking.
What is the stock of DARE Pharma?
$ 1.3400CloseChgChg %$1.36000.01000.74%
What will Microsoft stock be 2030?
The data forecast expected that Microsoft share price is predicted to rise to $302 by the end of 2022, $350 in 2023, $420 in 2024, $505 in 2025, $600 in 2026, $690 in 2027, $740 in 2028 and $770 in 2029. Microsoft (MSFT) stock prediction for 2030 is expected to reach $810.
How will Microsoft stock do in 2022?
Microsoft Stock Price Forecast 2022-2023 The forecasted Microsoft price at the end of 2022 is $300 – and the year to year change -11%. The rise from today to year-end: +19%.
What is Tesla stock prediction?
Stock Price Forecast The 37 analysts offering 12-month price forecasts for Tesla Inc have a median target of 1,000.00, with a high estimate of 1,620.00 and a low estimate of 250.00. The median estimate represents a +36.07% increase from the last price of 734.90.
How many shares of figs are there?
164.77 million sharesShare Statistics FIGS, Inc. has 164.77 million shares outstanding.
Why are figs Scrubs always sold out?
Secondly, it’s likely because it was a Limited Edition color. We order those in smaller quantities, and once they’re sold out, they’re gone! Sometimes we’ll restock a super popular color, so there’s a tiny chance it will come back.
Do figs restock?
All sizes of our Core Scrubs are replenished frequently and should never be out of stock. Our Limited Edition scrubs are ordered in smaller quantities and typically sell out FAST. If your size is sold out in a Limited Edition style, it may be gone for good — but don’t worry! There will be something else soon!
Should I buy or sell FIGS stock right now?
11 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for FIGS in the last year. There are currently 4 hold ratings and 7 buy ratin…
What is FIGS’s stock price forecast for 2022?
11 brokerages have issued twelve-month target prices for FIGS’s shares. Their forecasts range from $12.00 to $45.00. On average, they anticipate FI…
How has FIGS’s stock performed in 2022?
FIGS’s stock was trading at $27.56 on January 1st, 2022. Since then, FIGS shares have decreased by 71.8% and is now trading at $7.76. View the bes…
Are investors shorting FIGS?
FIGS saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 14,810,000 shares, a drop of 26.9% from th…
When is FIGS’s next earnings date?
FIGS is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for FIGS .
How were FIGS’s earnings last quarter?
FIGS, Inc. (NYSE:FIGS) released its earnings results on Thursday, May, 12th. The company reported $0.05 earnings per share (EPS) for the quarter, m…
What guidance has FIGS issued on next quarter’s earnings?
FIGS issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided EPS guidance of for the period. The company iss…
Who are FIGS’s key executives?
FIGS’s management team includes the following people: Ms. Heather L. Hasson , Co-Founder, Chairman & Co-CEO (Age 40, Pay $1.85M) Ms. Catherine S…
Who are some of FIGS’s key competitors?
Some companies that are related to FIGS include Under Armour (UAA) , Columbia Sportswear (COLM) , Carter’s (CRI) , Canada Goose (GOOS) , G-III…
How much did FIGS make in 2020?
The company made a profit of $49.8 million in 2020, compared with $0.1 million in 2019. Figs said that it sells 98 percent of its products via its digital platform, which includes its website and mobile application. FIGS stock is now trading at a 2020 price-to-sales multiple of 22.8x.
How much did FIGS raise?
On its first day of trading on the NYSE, FIGS stock surged 36 percent. The company plans to raise roughly $580 million in the offering.
How many shares did Tulco offer?
A total of 26.4 million shares were offered in the IPO at $22 per share. Initially, the offering was for 22.5 million shares at $16–$19. The company offered 4.6 million shares (down from an expected 5.9 million shares) and its largest investor, Tulco, offered 21.7 million shares (up from an expected 16.6 million shares). Tulco raised nearly $478 million in the $580 million IPO. The IPO is set to close on June 1, subject to customary closing conditions.
How many customers does Figs have in 2020?
Figs grew its active customer base by 118 percent from 0.6 million in 2019 to 1.3 million in 2020. Demand for its products jumped during the coronavirus pandemic.
Is FIGS stock a good investment?
FIGS stock looks like a good long-term investment. In its prospectus, Figs claims that it’s the largest DTC platform in the healthcare apparel market. The company serves the largest and fastest-growing job segment (healthcare) in the U.S. According to Frost & Sullivan, Figs’ total addressable market (TAM) was $12 billion in the U.S. in 2020. Over the next five years, the U.S. TAM is projected to expand at a compound annual rate of 6 percent.
Is FIGS stock going to pull back?
FIGS stock is expected to pull back after the IPO euphoria fizzles out. There’s no guarantee that the demand for its product will continue. The stock was up just 0.3 percent in premarket trading on May 28.
When is the IPO closing?
The IPO is set to close on June 1, subject to customary closing conditions. Article continues below advertisement. Goldman Sachs, Morgan Stanley, Barclays Capital, and Credit Suisse are acting as lead underwriters for the offering.
What is the price to sales multiple for FIGS 2020?
The IPO terms put the FIGS 2020 price-to-sales multiple at 12.9x, which looks attractive compared with that of high-growth, direct-to-consumer peer Eargo.
What does FIGS sell?
FIGS sells medical scrubs and healthcare apparel using a direct-to-consumer model. The company’s products also include lab coats, socks, and face masks and shields. FIGS has grown rapidly and is profitable, which is unusual for a pre-IPO company.
How much is healthcare apparel worth in 2020?
In 2020, the total addressable market for healthcare apparel was worth $12 billion in the U.S. and $79 billion worldwide, according to an April 2021 Frost & Sullivan report. Article continues below advertisement.
Is FIGS stock going up?
FIGS stock is expected to rise after its public debut, with demand for the company’s products soaring amid the coronavirus pandemic. The company has ramped up production to meet the needs of healthcare professionals. FIGS is also looking at expanding into other locations and professions.
Should you buy FIGS IPO stock?
The FIGS IPO stock looks like a good buy based on valuation and growth. The company’s revenue in 2020 rose by 138 percent year-over-year to $263.1 million. Between 2017 and 2020, the company’s revenue grew 146 percent compounded annually, boosted by its active customer count increasing from 0.6 million in 2019 to 1.3 million in 2020. The company’s net income rose to $49.8 million in 2020 from $0.1 million in 2019.
FIGS earnings per share forecast
What is FIGS ‘s earnings per share in the next 3 years based on estimates from 5 analyst s?
FIGS revenue forecast
What is FIGS ‘s revenue in the next 3 years based on estimates from 2 analyst s?
Historical and forecast chart of FIGS stock
The chart below shows the historical price of FIGS stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the FIGS stock price can be found in the table below.
FIGS Daily Price Targets
Forecast target price for 02-22-2022: $ 17.46. Positive dynamics for FIGS shares will prevail with possible volatility of 3.393%.
FIGS forecast for this year
An downtrend is forecast for this month with an optimal target price of $ 15.3514. Pessimistic: $13.72. Optimistic: $17.07
FIGS information and performance
FIGS, Inc. operates in the United States as a clothing and health products company. It develops and markets medical clothing and other non-dishwashing products such as lab coats, underwear, outerwear, sportswear, indoor clothing, compression socks, shoes, masks and face shields.